RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 EMPHASIS-HF: An Analysis of the High-Risk Groups
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 10
SP 14
OP 15
DO 10.1177/155989771110006
UL http://mdc.sagepub.com/content/11/10/14.abstract
AB Recent results from the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure [EMPHASIS-HF] trial showed that eplerenone, compared with placebo, significantly reduced the risk of the composite of cardiovascular death and hospitalization for heart failure in patients with chronic systolic NYHA class II HF [NCT00232180; Zannad F et al. N Engl J Med 2011].